Welcome to our dedicated page for Arteris SEC filings (Ticker: AIP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Arteris, Inc. (Nasdaq: AIP) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Arteris describes itself as a global leader in system IP used in semiconductors, and its filings offer formal detail on the financial and operational aspects behind that business.
Among the key documents are current reports on Form 8-K, which Arteris uses to furnish press releases announcing quarterly financial results and other material events. For example, the company has filed 8-Ks referencing press releases on results for quarters ended June 30 and September 30, including metrics such as revenue, licensing and royalty performance, operating loss, and Remaining Performance Obligations. These filings give investors structured insight into how Arteris’ licensing, support and maintenance, and variable royalty revenue streams are evolving.
Users can also review other periodic reports, such as Forms 10-Q and 10-K when available, to understand topics like segment performance, risk factors, and detailed financial statements that complement the high-level figures cited in press releases. For those interested in governance and ownership, SEC filings are the place where proxy statements and beneficial ownership reports would appear.
Stock Titan enhances this information by pairing real-time updates from EDGAR with AI-powered summaries that highlight the main points of lengthy filings. Instead of reading every line of a multi-page 10-K or 10-Q, users can rely on AI explanations to quickly identify revenue trends, key risks, and notable changes. The platform also surfaces insider transaction reports on Form 4 when filed, helping investors monitor trading activity by Arteris officers and directors.
By using this page, investors and researchers can efficiently navigate Arteris’ official SEC disclosures, from earnings-related 8-Ks to comprehensive annual and quarterly reports, supported by AI tools that make complex documents easier to interpret.
Arteris, Inc. (AIP) insider Moll Laurent R, Chief Operating Officer and director, reported stock dispositions on 09/02/2025. The Form 4 shows three sales executed at $8.9417 per share: 868 shares, 17,264 shares and 24,560 shares. The filings show remaining beneficial ownership after each sale of 441,203; 423,939; and 399,379 shares, respectively. The Form states the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units.
The Form 4 was signed by an attorney-in-fact on 09/03/2025. The disclosure documents the officer’s routine tax-related stock withholding and satisfies Section 16 reporting obligations.
Janac K. Charles, who serves as President and CEO, a director and a >10% owner of Arteris, Inc. (AIP), reported a sale of 1,246 shares of common stock on 09/02/2025 at a price of $8.9417 per share to satisfy the reporting person’s tax liability arising from the release of restricted stock units. After the transaction, the filing shows 188,539 shares beneficially owned directly by the reporting person, plus 9,839,071 shares indirectly held by Bayview Legacy, LLC and 56,252 shares indirectly held by the Charles and Lydia Janac Trust. The filer is the manager of Bayview Legacy, LLC and trustee of the trust. The Form 4 was signed by an attorney-in-fact on 09/03/2025.
Arteris, Inc. (AIP) Form 4: Nicholas B. Hawkins, Vice President and Chief Financial Officer, reported a sale of 438 shares of Arteris common stock on 09/02/2025 at a price of $8.9417 per share. The filing states the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units. After the transaction Hawkins beneficially owned 107,558 shares, held directly. The form was signed by an attorney-in-fact on behalf of Hawkins on 09/03/2025.
Arteris, Inc. (AIP) reporting person Paul L. Alpern, VP and General Counsel, disclosed a routine sale of common stock on 09/02/2025. The Form 4 shows 258 shares sold at $8.9417 per share under transaction code S(1), with the filing explaining the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units. Following the sale, Mr. Alpern beneficially owns 76,289 shares directly. The form is signed by Paul Alpern on 09/03/2025 and indicates a single reporting person filing.
Arteris, Inc. (AIP) Form 4 filing: 10% owner Bayview Legacy, LLC, managed by CEO K. Charles Janac, reported the sale of 50,000 common shares on 08/05/2025. The trade, executed under a Rule 10b5-1 plan adopted 03/05/2025, was coded “S” (open-market sale). Weighted-average price: $13.1199, with individual transactions between $12.35 and $14.20.
Following the sale, Bayview Legacy’s indirect beneficial ownership stands at 9,839,071 shares. No derivative transactions were reported. Janac has filed a separate Form 4 reflecting the same activity due to his control of the LLC.
The disposition represents roughly 0.5% of Bayview Legacy’s post-transaction holdings, leaving the insider with a substantial stake and signaling limited portfolio rebalancing rather than a material exit.